tiprankstipranks
Trending News
More News >
ABIONYX Pharma SA (GB:0RAG)
:0RAG

ABIONYX Pharma SA (0RAG) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

ABIONYX Pharma SA has a market cap or net worth of €41.58M. The enterprise value is -€206.11K.
Market Cap€41.58M
Enterprise Value-€206.11K

Share Statistics

ABIONYX Pharma SA has 34,931,010 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding34,931,010
Owned by Insiders
Owned by Institutions

Financial Efficiency

ABIONYX Pharma SA’s return on equity (ROE) is -0.59 and return on invested capital (ROIC) is -34.21%.
Return on Equity (ROE)-0.59
Return on Assets (ROA)-0.33
Return on Invested Capital (ROIC)-34.21%
Return on Capital Employed (ROCE)-0.46
Revenue Per Employee90.20K
Profits Per Employee-85.90K
Employee Count51
Asset Turnover0.34
Inventory Turnover17.54

Valuation Ratios

The current PE Ratio of ABIONYX Pharma SA is -9.11. ABIONYX Pharma SA’s PEG ratio is -0.03.
PE Ratio-9.11
PS Ratio0.00
PB Ratio1.04
Price to Fair Value5.40
Price to FCF-1.76
Price to Operating Cash Flow-1.76
PEG Ratio-0.03

Income Statement

In the last 12 months, ABIONYX Pharma SA had revenue of 4.60M and earned -4.40M in profits. Earnings per share was -0.14.
Revenue4.60M
Gross Profit900.00K
Operating Income-4.50M
Pretax Income-5.47M
Net Income-4.40M
EBITDA-4.33M
Earnings Per Share (EPS)-0.14

Cash Flow

In the last 12 months, operating cash flow was -3.60M and capital expenditures 0.00, giving a free cash flow of -3.60M billion.
Operating Cash Flow-3.60M
Free Cash Flow-3.60M
Free Cash Flow per Share-0.10

Dividends & Yields

ABIONYX Pharma SA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-0.05
52-Week Price Change0.81%
50-Day Moving Average1.25
200-Day Moving Average1.26
Relative Strength Index (RSI)42.91
Average Volume (3m)16.00

Important Dates

ABIONYX Pharma SA upcoming earnings date is Sep 25, 2025, During Market Hours (Confirmed).
Last Earnings DateMar 6, 2025
Next Earnings DateSep 25, 2025
Ex-Dividend Date

Financial Position

ABIONYX Pharma SA as a current ratio of 1.58, with Debt / Equity ratio of 17.75%
Current Ratio1.58
Quick Ratio1.52
Debt to Market Cap0.04
Net Debt to EBITDA0.11
Interest Coverage Ratio0.00

Taxes

In the past 12 months, ABIONYX Pharma SA has paid -1.07M in taxes.
Income Tax-1.07M
Effective Tax Rate0.20

Enterprise Valuation

ABIONYX Pharma SA EV to EBITDA ratio is -9.15, with an EV/FCF ratio of -11.01.
EV to Sales8.61
EV to EBITDA-9.15
EV to Free Cash Flow-11.01
EV to Operating Cash Flow-11.01

Balance Sheet

ABIONYX Pharma SA has €3.23M in cash and marketable securities with €2.76M in debt, giving a net cash position of -€478.00K billion.
Cash & Marketable Securities€3.23M
Total Debt€2.76M
Net Cash-€478.00K
Net Cash Per Share-€0.01
Tangible Book Value Per Share€0.06

Margins

Gross margin is 0.00%, with operating margin of -97.83%, and net profit margin of -95.65%.
Gross Margin0.00%
Operating Margin-97.83%
Pretax Margin-118.85%
Net Profit Margin-95.65%
EBITDA Margin-94.13%
EBIT Margin-95.65%

Analyst Forecast

The average price target for ABIONYX Pharma SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis